Related Experiment Videos
Indirect serotonergic agonists attenuate neuronal opiate withdrawal
1Department of Mental Health Sciences, Hahnemann University, Philadelphia, PA 19102.
Neuroscience
|June 1, 1993
Summary
Serotonin (5-HT) systems can reduce hyperactivity in noradrenergic locus coeruleus (LC) neurons during opiate withdrawal. This finding offers potential for new treatments for opioid dependence, avoiding side effects of current therapies.
Area of Science:
- Neuroscience
- Pharmacology
- Addiction Research
Background:
- Opiate withdrawal causes severe symptoms due to noradrenergic locus coeruleus (LC) hyperactivity.
- Current treatments like methadone and clonidine have significant side effects.
- Novel pharmacotherapies are needed to manage opiate withdrawal symptoms and dependence.
Purpose of the Study:
- To investigate the potential of enhanced serotonergic neurotransmission as an alternative treatment for opiate withdrawal.
- To determine if increasing serotonin activity can reduce LC neuron hyperactivity during withdrawal.
Main Methods:
- Utilized a rat model of chronic morphine exposure and naloxone-precipitated withdrawal.
- Measured the hyperactivity of noradrenergic LC neurons.
- Administered agents that enhance serotonergic neurotransmission, including d-fenfluramine, fluoxetine, and sertraline.
Main Results:
- Agents increasing serotonergic neurotransmission significantly attenuated withdrawal-induced hyperactivity of LC neurons.
- d-fenfluramine, fluoxetine, and sertraline demonstrated efficacy in reducing LC hyperactivity.
- This suggests a role for serotonin in modulating the neurobiological underpinnings of opiate withdrawal.
Conclusions:
- Enhanced serotonergic neurotransmission is a viable strategy to reduce opiate withdrawal-induced LC hyperactivity.
- Serotonin-acting agents may offer a promising alternative to current pharmacotherapies for opioid dependence.
- Further research into serotonin's role could lead to improved treatments for addiction.